BACKGROUND: The immune and blood coagulation systems have been implicated in the pathophysiology of the geriatric syndrome of frailty, but limited prospective data examining the relationship of clotting/inflammation biomarkers to risk of incident frailty exist. METHODS: This prospective analysis was derived from a nested case-control study within the Women's Health Initiative. Among women 65 to 79 years free of frailty at enrollment, we randomly selected 900 incident cases from those developing frailty within 3 years; 900 non-frail controls were individually matched on age, ethnicity, and blood collection date. Biomarkers assessed for risk of incident frailty included fibrinogen, factor VIII, D-dimer, C-reactive protein, interleukin-6, and tissue plasminogen activator (t-PA). RESULTS: When examined by quartiles in multivariable adjusted models, higher D-dimer and t-PA levels were each associated with increased risk of frailty (P trend = .04). Relative to the lowest quartile, the odds ratios for frailty compared with the upper quartile were 1.52 (95% confidence interval, 1.05-2.22) for t-PA and 1.57 (95% confidence interval, 1.11-2.22) for D-dimer. For women having high t-PA and high D-dimer compared with women having lower levels of both biomarkers, the odds of frailty was 2.20 (1.29-3.75). There was little evidence for association between coagulation factor VIII, fibrinogen, C-reactive protein, or interleukin-6 levels and incident frailty. CONCLUSION: This prospective analysis supports the role of markers of fibrin turnover and fibrinolysis as independent predictors of incident frailty in postmenopausal women.
BACKGROUND: The immune and blood coagulation systems have been implicated in the pathophysiology of the geriatric syndrome of frailty, but limited prospective data examining the relationship of clotting/inflammation biomarkers to risk of incident frailty exist. METHODS: This prospective analysis was derived from a nested case-control study within the Women's Health Initiative. Among women 65 to 79 years free of frailty at enrollment, we randomly selected 900 incident cases from those developing frailty within 3 years; 900 non-frail controls were individually matched on age, ethnicity, and blood collection date. Biomarkers assessed for risk of incident frailty included fibrinogen, factor VIII, D-dimer, C-reactive protein, interleukin-6, and tissue plasminogen activator (t-PA). RESULTS: When examined by quartiles in multivariable adjusted models, higher D-dimer and t-PA levels were each associated with increased risk of frailty (P trend = .04). Relative to the lowest quartile, the odds ratios for frailty compared with the upper quartile were 1.52 (95% confidence interval, 1.05-2.22) for t-PA and 1.57 (95% confidence interval, 1.11-2.22) for D-dimer. For women having high t-PA and high D-dimer compared with women having lower levels of both biomarkers, the odds of frailty was 2.20 (1.29-3.75). There was little evidence for association between coagulation factor VIII, fibrinogen, C-reactive protein, or interleukin-6 levels and incident frailty. CONCLUSION: This prospective analysis supports the role of markers of fibrin turnover and fibrinolysis as independent predictors of incident frailty in postmenopausal women.
Authors: Roland von Känel; Joel E Dimsdale; Paul J Mills; Sonia Ancoli-Israel; Thomas L Patterson; Brent T Mausbach; Igor Grant Journal: J Gerontol A Biol Sci Med Sci Date: 2006-09 Impact factor: 6.053
Authors: Aaron R Folsom; Lori L Boland; Mary Cushman; Susan R Heckbert; Wayne D Rosamond; Jeremy D Walston Journal: J Gerontol A Biol Sci Med Sci Date: 2007-01 Impact factor: 6.053
Authors: Nancy Fugate Woods; Andrea Z LaCroix; Shelly L Gray; Aaron Aragaki; Barbara B Cochrane; Robert L Brunner; Kamal Masaki; Anne Murray; Anne B Newman Journal: J Am Geriatr Soc Date: 2005-08 Impact factor: 5.562
Authors: Jeremy Walston; Neal Fedarko; Huanle Yang; Sean Leng; Brock Beamer; Sara Espinoza; Anne Lipton; Howie Zheng; Kevin Becker Journal: J Gerontol A Biol Sci Med Sci Date: 2008-04 Impact factor: 6.053
Authors: Brent T Mausbach; Roland von Känel; Kirstin Aschbacher; Susan K Roepke; Joel E Dimsdale; Michael G Ziegler; Paul J Mills; Thomas L Patterson; Sonia Ancoli-Israel; Igor Grant Journal: Psychosom Med Date: 2007-10-17 Impact factor: 4.312
Authors: Kinza S Shamsi; Anson Pierce; Aaron S Ashton; Dipti G Halade; Arlan Richardson; Sara E Espinoza Journal: J Gerontol A Biol Sci Med Sci Date: 2012-01-04 Impact factor: 6.053
Authors: Andrea L Rosso; Charles B Eaton; Robert Wallace; Rachel Gold; J David Curb; Marcia L Stefanick; Judith K Ockene; Yvonne L Michael Journal: J Gerontol A Biol Sci Med Sci Date: 2011-02-11 Impact factor: 6.053
Authors: Eveline Nüesch; Caroline E Dale; Antoinette Amuzu; Hannah Kuper; Ann Bowling; George B Ploubidis; Gordon Lowe; Ann Rumley; Shah Ebrahim; Juan P Casas Journal: Eur J Epidemiol Date: 2012-06-19 Impact factor: 8.082
Authors: Candace K McClure; Samar R El Khoudary; Carrie A Karvonen-Gutierrez; Kelly R Ylitalo; Kristin Tomey; Trang VoPham; Barbara Sternfeld; Jane A Cauley; Siobán Harlow Journal: Exp Gerontol Date: 2013-11-07 Impact factor: 4.032